I don’t know that they have announced the date,

I don’t know that they have announced the date, but I believe they do have a meeting for FDA decision (and hopefully approval on 525 mg vs 700 mg? This may not be a meeting, but could likely be the criteria for a larger pharma discussion about combo license as it directly impacts BLA submission timeline.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.